{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:15:31Z","timestamp":1789848931075,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1038\/bjc.2012.556","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T23:55:17Z","timestamp":1357257317000},"page":"21-24","source":"Crossref","is-referenced-by-count":67,"title":["A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis"],"prefix":"10.1038","volume":"108","author":[{"given":"A","family":"Santoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Simonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Rodriguez-Lope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Zucali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L H","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Granito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Senzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Rimassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Abbadessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R E","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Bruix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,3]]},"reference":[{"issue":"6","key":"BFbjc2012556_CR1","first-page":"404","volume":"13","author":"R Bagai","year":"2010","unstructured":"Bagai R, Fan W, Ma PC (2010) ARQ-197, an oral small molecule inhibitor of c-Met for the treatment of solid tumors. IDrugs 13 (6): 404\u2013414","journal-title":"IDrugs"},{"key":"BFbjc2012556_CR2","doi-asserted-by":"crossref","unstructured":"Bathala MS, Nakai D, Murai T, Pickersgill F, Zahir H, Tokui T (2012) Absorption, distribution, metabolism, and excretion of 14C-labeled tivantinib (ARQ 197) in healthy male subjects. 103rd Annual Meeting of the American Association for Cancer Research 31 Mar\u20134 Apr 2012; Chicago, IL. Abstract 747","DOI":"10.1158\/1538-7445.AM2012-747"},{"issue":"1","key":"BFbjc2012556_CR3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.1840190115","volume":"19","author":"L Boix","year":"1994","unstructured":"Boix L, Rosa JL, Ventura F, Castells A, Bruix J, Rodes J, Bartrons R (1994) c-met mRNA overexpression in human hepatocellular carcinoma. Hepatology 19 (1): 88\u201391","journal-title":"Hepatology"},{"issue":"5","key":"BFbjc2012556_CR4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","volume":"42","author":"J Bruix","year":"2005","unstructured":"Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42 (5): 1208\u20131236","journal-title":"Hepatology"},{"issue":"3","key":"BFbjc2012556_CR5","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53 (3): 1020\u20131022","journal-title":"Hepatology"},{"issue":"1","key":"BFbjc2012556_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","volume":"10","author":"AL Cheng","year":"2009","unstructured":"Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z (2009) Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10 (1): 25\u201334","journal-title":"Lancet Oncol"},{"key":"BFbjc2012556_CR7","unstructured":"CTCAE (2006) Common Terminology Criteria for Adverse Events version 3.0 http:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcaev3.pdf"},{"issue":"4","key":"BFbjc2012556_CR8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"EASL-EORTC","year":"2012","unstructured":"EASL-EORTC (2012) European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 56 (4): 908\u2013943","journal-title":"J Hepatol"},{"issue":"9822","key":"BFbjc2012556_CR9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379 (9822): 1245\u20131255","journal-title":"Lancet"},{"issue":"1","key":"BFbjc2012556_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.21966","volume":"47","author":"A Forner","year":"2008","unstructured":"Forner A, Vilana R, Ayuso C, Bianchi L, Sole M, Ayuso JR, Boix L, Sala M, Varela M, Llovet JM, Bru C, Bruix J (2008) Diagnosis of hepatic nodules 20\u2009mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47 (1): 97\u2013104","journal-title":"Hepatology"},{"issue":"6","key":"BFbjc2012556_CR11","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1172\/JCI27236","volume":"116","author":"P Kaposi-Novak","year":"2006","unstructured":"Kaposi-Novak P, Lee JS, Gomez-Quiroz L, Coulouarn C, Factor VM, Thorgeirsson SS (2006) Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest 116 (6): 1582\u20131595","journal-title":"J Clin Invest"},{"issue":"4","key":"BFbjc2012556_CR12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359 (4): 378\u2013390","journal-title":"N Engl J Med"},{"issue":"6","key":"BFbjc2012556_CR13","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1158\/1535-7163.MCT-09-1173","volume":"9","author":"N Munshi","year":"2010","unstructured":"Munshi N, Jeay S, Li Y, Chen CR, France DS, Ashwell MA, Hill J, Moussa MM, Leggett DS, Li CJ (2010) ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity. Mol Cancer Ther 9 (6): 1544\u20131553","journal-title":"Mol Cancer Ther"},{"key":"BFbjc2012556_CR14","unstructured":"NCCN (2011) National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology, Hepatobiliary Cancers, version 2.1012 http:\/\/www.nccn.org"},{"issue":"1","key":"BFbjc2012556_CR15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1158\/1535-7163.MCT-11-0277","volume":"11","author":"S Previdi","year":"2012","unstructured":"Previdi S, Abbadessa G, Dalo F, France DS, Broggini M (2012) Breast cancer-derived bone metastasis can be effectively reduced through specific c-MET inhibitor tivantinib (ARQ 197) and shRNA c-MET knockdown. Mol Cancer Ther 11 (1): 214\u2013223","journal-title":"Mol Cancer Ther"},{"issue":"24","key":"BFbjc2012556_CR16","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1158\/1078-0432.CCR-11-1002","volume":"17","author":"LS Rosen","year":"2011","unstructured":"Rosen LS, Senzer N, Mekhail T, Ganapathi R, Chai F, Savage RE, Waghorne C, Abbadessa G, Schwartz B, Dreicer R (2011) A phase I dose-escalation study of Tivantinib (ARQ 197) in adult patients with metastatic solid tumors. Clin Cancer Res 17 (24): 7754\u20137764","journal-title":"Clin Cancer Res"},{"issue":"2","key":"BFbjc2012556_CR17","first-page":"451","volume":"31","author":"A Salvi","year":"2007","unstructured":"Salvi A, Arici B, Portolani N, Giulini SM, De Petro G, Barlati S (2007) In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells. Int J Oncol 31 (2): 451\u2013460","journal-title":"Int J Oncol"},{"key":"BFbjc2012556_CR18","doi-asserted-by":"crossref","unstructured":"Santoro A, Rimassa L, Borbath I, Daniele B, Salvagni S, Van Laethem JL, Van Vlieberghe H, Trojan J, Kolligs FT, Weiss A, Miles S, Gasbarrini A, Lencioni M, Cicalese L, Sherman M, Gridelli C, Buggish P, Gerken G, Schmid RM, Boni C, Personeni N, Hassoun Z, Abbadessa G, Schwartz B, Von Roemeling R, Lamar ME, Chen Y, Porta C (2012) Efficacy and safety of tivantinib as second-line therapy for advanced hepatocellular carcinoma: a phase 2, randomized, placebo-controlled study. Lancet Oncol e-pub ahead of print 19 November 2012; doi: 10.1016\/S1470-2045(12)70490-4","DOI":"10.1016\/S1470-2045(12)70490-4"},{"issue":"24","key":"BFbjc2012556_CR19","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1200\/JCO.2010.34.0570","volume":"29","author":"LV Sequist","year":"2011","unstructured":"Sequist LV, von Pawel J, Garmey EG, Akerley WL, Brugger W, Ferrari D, Chen Y, Costa DB, Gerber DE, Orlov S, Ramlau R, Arthur S, Gorbachevsky I, Schwartz B, Schiller JH (2011) Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancer. J Clin Oncol 29 (24): 3307\u20133315","journal-title":"J Clin Oncol"},{"issue":"12","key":"BFbjc2012556_CR20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","volume":"64","author":"RK Verbeeck","year":"2008","unstructured":"Verbeeck RK (2008) Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol 64 (12): 1147\u20131161","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"BFbjc2012556_CR21","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.153.5.1023","volume":"153","author":"R Wang","year":"2001","unstructured":"Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM (2001) Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol 153 (5): 1023\u20131034","journal-title":"J Cell Biol"},{"issue":"2","key":"BFbjc2012556_CR22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jss.2009.04.030","volume":"162","author":"B Xie","year":"2010","unstructured":"Xie B, Xing R, Chen P, Gou Y, Li S, Xiao J, Dong J (2010) Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference. J Surg Res 162 (2): 231\u2013238","journal-title":"J Surg Res"},{"issue":"10","key":"BFbjc2012556_CR23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1200\/JCO.2010.31.0367","volume":"29","author":"TA Yap","year":"2011","unstructured":"Yap TA, Olmos D, Brunetto AT, Tunariu N, Barriuso J, Riisnaes R, Pope L, Clark J, Futreal A, Germuska M, Collins D, deSouza NM, Leach MO, Savage RE, Waghorne C, Chai F, Garmey E, Schwartz B, Kaye SB, de Bono JS (2011) Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies. J Clin Oncol 29 (10): 1271\u20131279","journal-title":"J Clin Oncol"},{"issue":"suppl 9","key":"BFbjc2012556_CR24","doi-asserted-by":"crossref","first-page":"ix244","DOI":"10.1016\/S0923-7534(20)33319-6","volume":"23","author":"H Zahir","year":"2012","unstructured":"Zahir H, Kastrissios H, Carothers T, Jansen M, Mendel J, Savage R, Abbadessa G, Chai F, Schwartz B, Miller R, Tokui T (2012) Exposure-response relationship to assess the risk of neutropenia in patients with hepatocellular carcinoma (HCC) treated with tivantinib. Ann Oncol 23 (suppl 9): ix244\u2013ix245, Abstract 738P","journal-title":"Ann Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2012556.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012556","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012556.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T11:30:10Z","timestamp":1687951810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2012556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["BFbjc2012556"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2012.556","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}